Literature DB >> 9593385

Congenital esotropia in Olmsted County, Minnesota.

B G Mohney1, J C Erie, D O Hodge, S J Jacobsen.   

Abstract

OBJECTIVE: To determine the birth prevalence of and risk factors associated with congenital esotropia.
DESIGN: Population-based prevalence study with nested case-control study. PARTICIPANTS: All residents of Olmsted County, Minnesota who were diagnosed with congenital esotropia and born between January 1, 1980 and December 31, 1989 (n = 47). Control subjects were chosen by selecting the next two sequential births to parents residing in Olmsted County, Minnesota (n = 94).
METHODS: Cases were identified through the Medical Diagnostic Index of Mayo and the Rochester Epidemiology Project. The community medical records were reviewed to confirm case status and ascertain risk factor information. MAIN OUTCOME MEASURE: Birth prevalence of congenital esotropia.
RESULTS: Forty-seven cases were identified from 17,536 live births, for a birth prevalence of 27 per 10,000 (95% confidence interval [CI], 20-35). Congenital esotropia was associated with prematurity (odds ratio [OR], 11.5; 95% CI, 3.4-39.2), a birth weight less than 2500 grams (OR, 4.6; 95% CI, 1.7-12.9), a low Apgar score at 1 minute (OR, 4.3; 95% CI, 1.7-11.2) and at 5 minutes (OR, 6.3; 95% CI, 1.3-30.7), and a family history of strabismus (OR, 3.5; 95% CI, 1.5-8.3).
CONCLUSIONS: The birth prevalence of congenital esotropia in Olmsted County, Minnesota is lower than previous estimates. Prematurity, low birth weight, low Apgar scores, and a family history of strabismus are significant risk factors for congenital esotropia.

Entities:  

Mesh:

Year:  1998        PMID: 9593385     DOI: 10.1016/S0161-6420(98)95024-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

Review 1.  The genetics of strabismus.

Authors:  M Michaelides; A T Moore
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

Review 2.  Why do only some hyperopes become strabismic?

Authors:  Erin Babinsky; T Rowan Candy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-24       Impact factor: 4.799

3.  Congenital esotropia and the risk of mental illness by early adulthood.

Authors:  Joshua H Olson; Curtis R Louwagie; Nancy N Diehl; Brian G Mohney
Journal:  Ophthalmology       Date:  2011-10-08       Impact factor: 12.079

4.  Effect of gestational age and birth weight on the risk of strabismus among premature infants.

Authors:  Shilpa Gulati; Chris A Andrews; Alexandra O Apkarian; David C Musch; Paul P Lee; Joshua D Stein
Journal:  JAMA Pediatr       Date:  2014-09       Impact factor: 16.193

5.  Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates.

Authors:  Deborah K VanderVeen; Elizabeth N Allred; David K Wallace; Alan Leviton
Journal:  J Child Neurol       Date:  2015-09-08       Impact factor: 1.987

6.  Is the incidence of infantile esotropia declining?: a population-based study from Olmsted County, Minnesota, 1965 to 1994.

Authors:  Curtis R Louwagie; Nancy N Diehl; Amy E Greenberg; Brian G Mohney
Journal:  Arch Ophthalmol       Date:  2009-02

Review 7.  Timing of surgery for infantile esotropia: sensory and motor outcomes.

Authors:  Agnes M F Wong
Journal:  Can J Ophthalmol       Date:  2008-12       Impact factor: 1.882

8.  Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 Years of age.

Authors:  Achim Fieß; Ruth Kölb-Keerl; Alexander K Schuster; Markus Knuf; Bernd Kirchhof; Philipp S Muether; Jacqueline Bauer
Journal:  BMC Ophthalmol       Date:  2017-12-02       Impact factor: 2.209

9.  Recurrent Rare Copy Number Variants Increase Risk for Esotropia.

Authors:  Mary C Whitman; Silvio Alessandro Di Gioia; Wai-Man Chan; Alon Gelber; Brandon M Pratt; Jessica L Bell; Thomas E Collins; James A Knowles; Christopher Armoskus; Michele Pato; Carlos Pato; Sherin Shaaban; Sandra Staffieri; Sarah MacKinnon; Gail D E Maconachie; James E Elder; Elias I Traboulsi; Irene Gottlob; David A Mackey; David G Hunter; Elizabeth C Engle
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.